Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline

Azargoonjahromi A.

J Pharm Pharmacol. 2024 Sep 3;76(9):1115-1131. doi: 10.1093/jpp/rgae066.

Sarcopenia as a Risk Factor for Alzheimer's Disease: Genetic and Epigenetic Perspectives

Raleigh SM, Orchard KJA.

Genes (Basel). 2024 Apr 27;15(5):561. doi: 10.3390/genes15050561.

Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease

Li J, Haj Ebrahimi A, Ali AB.

Int J Mol Sci. 2024 May 9;25(10):5169. doi: 10.3390/ijms25105169.

MEM&SO protocol: understanding the determinants of social learning in neurodegenerative diseases

Saliou P, Chavant J, Belliard S, Merck C, de La Sayette V, Wallon D, Martinaud O, Eustache F, Laisney M.

BMC Psychol. 2024 May 28;12(1):307. doi: 10.1186/s40359-024-01791-w.

Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-AD(mini) randomized controlled trial

Thunborg C, Wang R, Rosenberg A, Sindi S, Andersen P, Andrieu S, Broersen LM, Coley N, Couderc C, Duval CZ, Faxen-Irving G, Hagman G, Hallikainen M, Håkansson K, Kekkonen E, Lehtisalo J, Levak N, Mangialasche F, Pantel J, Rydström A, Stigsdotter-Neely A, Wimo A, Ngandu T, Soininen H, Hartmann T, Solomon A, Kivipelto M.

Alzheimers Res Ther. 2024 May 30;16(1):118. doi: 10.1186/s13195-024-01468-x.

Beyond memory impairment: the complex phenotypic landscape of Alzheimer's disease

Argyriou S, Fullard JF, Krivinko JM, Lee D, Wingo TS, Wingo AP, Sweet RA, Roussos P.

Trends Mol Med. 2024 Aug;30(8):713-722. doi: 10.1016/j.molmed.2024.04.016. Epub 2024 May 30.

Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease

Wang HJ, Chinna-Meyyappan A, Feldman OJ, Lanctôt KL.

Expert Opin Emerg Drugs. 2024 Sep;29(3):289-303. doi: 10.1080/14728214.2024.2363215. Epub 2024 Jun 11.

Does resistance training in older adults lead to structural brain changes associated with a lower risk of Alzheimer's dementia? A narrative review

Nicola L, Loo SJQ, Lyon G, Turknett J, Wood TR.

Ageing Res Rev. 2024 Jul;98:102356. doi: 10.1016/j.arr.2024.102356. Epub 2024 May 31.

Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N = 3,118

Kang X, Wang D, Lin J, Yao H, Zhao K, Song C, Chen P, Qu Y, Yang H, Zhang Z, Zhou B, Han T, Liao Z, Chen Y, Lu J, Yu C, Wang P, Zhang X, Li M, Zhang X, Jiang T, Zhou Y, Liu B, Han Y, Liu Y; Alzheimer’s Disease Neuroimaging Initiative; Multi-Center Alzheimer’s Disease Imaging (MCADI) Consortium.

Neurosci Bull. 2024 Sep;40(9):1274-1286. doi: 10.1007/s12264-024-01218-x. Epub 2024 Jun 1.

Cross-cultural adaptation and validation of the Australian National University Alzheimer Disease Risk Index (ANU-ADRI) for Chinese community-dwelling residents: A cross-sectional Study

Zhi S, Zhang S, Yang D, Sun J, Gao S, Song D, Ma D, Fang S, Zhong Q, Wu Y, Sun J.

Geriatr Nurs. 2024 Jul-Aug;58:225-231. doi: 10.1016/j.gerinurse.2024.05.031. Epub 2024 Jun 4.

Development of disease-modifying therapies against Alzheimer's disease

Iwatsubo T.

Psychiatry Clin Neurosci. 2024 Sep;78(9):491-494. doi: 10.1111/pcn.13681. Epub 2024 Jun 6.

The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed

Tavares-Júnior JWL, Ciurleo GCV, Feitosa EAAF, Oriá RB, Braga-Neto P.

J Alzheimers Dis. 2024;99(4):1159-1171. doi: 10.3233/JAD-231368.

Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial

Ornish D, Madison C, Kivipelto M, Kemp C, McCulloch CE, Galasko D, Artz J, Rentz D, Lin J, Norman K, Ornish A, Tranter S, DeLamarter N, Wingers N, Richling C, Kaddurah-Daouk R, Knight R, McDonald D, Patel L, Verdin E, E Tanzi R, Arnold SE.

Alzheimers Res Ther. 2024 Jun 7;16(1):122. doi: 10.1186/s13195-024-01482-z.

The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis

Liu Y, Xiao X, Yang Y, Yao R, Yang Q, Zhu Y, Yang X, Zhang S, Shen L, Jiao B.

Alzheimers Dement. 2024 Jul;20(7):4841-4853. doi: 10.1002/alz.14049. Epub 2024 Jun 11.

Distinct biological property of tau in tau-first cognitive proteinopathy: Evidence by longitudinal clinical neuroimaging profiles and compared with late-onset Alzheimer disease

Chang HI, Huang CW, Huang SH, Hsu SW, Lin KJ, Ho TY, Wu HC, Chang CC.

Psychiatry Clin Neurosci. 2024 Aug;78(8):446-455. doi: 10.1111/pcn.13680. Epub 2024 Jun 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias